PDCD1 and neoplasm: Mice treated with vehicle or with weekly anti-PD1, a checkpoint inhibitor used to activate tumor T cells (Topalian et al, 2016; Molgora et al, 2020), showed growing tumors, whereas SHP2 inhibitor shrank most tumors.